Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Wan Sub Shim"'
Autor:
Chul Woo Ahn, Sookyung Kim, Hae Jin Kim, Yong-Jik Lee, Bong Soo Cha, Zheng-Shan Zhao, Hyun Chul Lee, Wan-Sub Shim, Zhongmin Alex Ma
Publikováno v:
Life Sciences. 84:688-695
Aims Rosiglitazone and fenofibrate, specific agonists of the peroxisome proliferator activated receptors-γ (PPARγ) and -α (PPARα), respectively, improve insulin sensitivity in diabetic animals and in patients with type 2 diabetes. Here we investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffbefda908cb893a65fec253cc5229f
https://doi.org/10.1016/j.lfs.2009.02.021
https://doi.org/10.1016/j.lfs.2009.02.021
Autor:
Jae Hyuk Lee, Eun Seok Kang, Chul Woo Ahn, Hyun Chul Lee, Sung Kil Lim, Wan Sub Shim, Kyu Yeon Hur, Bong Soo Cha, Soo Kyung Kim, Hae Jin Kim
Publikováno v:
Diabetes Research and Clinical Practice. 81:42-49
Rosiglitazone (RSG) is known to be an agonist for the peroxisome proliferator-activated receptor-gamma (PPARgamma) and promotes differentiation of pre-adipocytes into adipocytes. Leptin is highly correlated with adiposity, while the activation of PPA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08df8a22816ae26c4180dfb536b3abff
https://doi.org/10.1016/j.diabres.2008.02.001
https://doi.org/10.1016/j.diabres.2008.02.001
Autor:
Eunjoo Kim, Hun Jae Lee, Yong Seong Kim, Seong Bin Hong, Moonsuk Nam, Eun A Kim, Wan Sub Shim, So Hun Kim, Shin Goo Park, Jong Whan Lim, Seung-Hee Lee
Publikováno v:
Yonsei Medical Journal
Purpose The aim of this study was to evaluate the effect of lowering the fasting plasma glucose (FPG) criteria for impaired fasting glucose (IFG) on the prevalence of IFG and the risk for the development of diabetes associated with IFG in Koreans. Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06ddfa82756a5a82b3151e6544bec905
http://europepmc.org/articles/PMC2615324
http://europepmc.org/articles/PMC2615324
Autor:
Wan Sub Shim, Bong Soo Cha, Soo Kyung Kim, Chul Woo Ahn, Eun Seok Kang, Tae Woo Jung, Ji Young Lee, Hyun Chul Lee
Publikováno v:
Journal of the Neurological Sciences. 253:53-60
1-Methyl-4-phenylpyridinium ion (MPP + ), an inhibitor of mitochondrial complex I, has been widely used as a neurotoxin because it elicits a severe Parkinson's disease-like syndrome with elevation of intracellular reactive oxygen species (ROS) level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa76eefd8b55e94f5666b203684190bc
https://doi.org/10.1016/j.jns.2006.11.020
https://doi.org/10.1016/j.jns.2006.11.020
Autor:
Wan Sub Shim, Mi Young Do, Soo Kyung Kim, Hae Jin Kim, Kyu Yeon Hur, Eun Seok Kang, Chul Woo Ahn, Sung Kil Lim, Hyun Chul Lee, Bong Soo Cha
Publikováno v:
Clinical Endocrinology. 65:453-459
Although rosiglitazone, an insulin sensitizer, is known to have beneficial effects on high density lipoprotein cholesterol (HDL-C) concentrations and low density lipoprotein (LDL) particle size, it has unwanted effects on total cholesterol (TC) and L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6832005428b930aca1ac5bac9cb13c15
https://doi.org/10.1111/j.1365-2265.2006.02614.x
https://doi.org/10.1111/j.1365-2265.2006.02614.x
Autor:
Chul Woo Ahn, Wan Sub Shim, Sung Kil Lim, Eun Seok Kang, Hae Jin Kim, Bong Soo Cha, Soo Kyung Kim, Hyun Chul Lee
Publikováno v:
European Journal of Endocrinology. 155:615-622
Objective: Type-2 diabetes is a progressive disease. However, little is known about whether decreased fasting or postprandial pancreatic β-cell responsiveness is more prominent with increased duration of diabetes. The aim of this study was to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be7f01f927620637f5d34a870c963bd0
https://doi.org/10.1530/eje.1.02249
https://doi.org/10.1530/eje.1.02249
Autor:
Chul Woo Ahn, Sung Kil Lim, Eun Seok Kang, Wan Sub Shim, Hyun Chul Lee, Bong Soo Cha, Hae Jin Kim
Publikováno v:
Diabetes Research and Clinical Practice. 73:284-291
Aims We investigated the relation between total and differential white blood cell (WBC) count and metabolic syndrome (MS) in type 2 diabetic patients. Methods Eight-hundred and twenty-two patients (males 430, females 392, BMI 25.4 ± 3.2 kg/m2, durat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f85019fbd7f81590fa0b5c149c92965b
https://doi.org/10.1016/j.diabres.2006.02.001
https://doi.org/10.1016/j.diabres.2006.02.001
Autor:
Sookyung Kim, Tae Woo Jung, Chul Woo Ahn, Wan Sub Shim, Hyun Chul Lee, Bong Soo Cha, Eun Seok Kang, Ji Young Lee
Publikováno v:
Alcohol and Alcoholism. 41:231-235
Aims: To assess the efficacy of rosiglitazone in blocking ethanol-induced hangover in rats. Methods: Rats injected with ethanol (4 g/kg body weight) were subjected to social interaction tests. Levels of aldehyde dehydrogenase 2 (ALD2), involved in an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d9bc4b2a1c1bc7954232fe35469e41d
https://doi.org/10.1093/alcalc/agl013
https://doi.org/10.1093/alcalc/agl013
Autor:
Eun Seok Kang, Tae Woo Jung, Ji Young Lee, Wan Sub Shim, Chul Woo Ahn, Bong Soo Cha, Soo Kyung Kim, Hyun Chul Lee
Publikováno v:
Biochemical and Biophysical Research Communications. 340:221-227
Acetaldehyde, an inhibitor of mitochondrial function, has been widely used as a neurotoxin because it elicits a severe Parkinson’s disease-like syndrome with elevation of the intracellular reactive oxygen species level and apoptosis. Rosiglitazone,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19edd46dee5041de4c198e927d2df830
https://doi.org/10.1016/j.bbrc.2005.11.177
https://doi.org/10.1016/j.bbrc.2005.11.177
Autor:
Soo Kyung Kim, Chul Woo Ahn, Hae Jin Kim, Wan Sub Shim, Yong Wook Cho, Hyun Chul Lee, Sung Kil Lim, Bong Soo Cha, Kyu Yeon Hur, Seok Won Park
Publikováno v:
European journal of endocrinology. 157(2)
Objective: The goal was to investigate the interrelationships between the hypoglycemic effects of rosiglitazone and the changes in the regional adiposity of type 2 diabetic patients. Design and methods: We added rosiglitazone (4 mg/day) to 173 diabet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d7ebf7e6c8cfe18790f3c1a195d731
https://pubmed.ncbi.nlm.nih.gov/17656594
https://pubmed.ncbi.nlm.nih.gov/17656594